Symbio Pharmaceuticals Ltd operates in the Commercial physical research sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Symbio Pharmaceuticals Ltd with three other
companies in this sector in Japan:
sales of 1.91 billion Japanese Yen [US$18.39 million]
of which 54%
was Cell Therapy Technology Development Busi),
Trans Genic Inc
(1.96 billion Japanese Yen [US$18.86 million]
Medinet Co., Ltd.
(1.67 billion Japanese Yen [US$16.12 million]
of which 100%
was cell processing).
Symbio Pharmaceuticals Ltd reported sales of ¥1.93 billion (US$18.62 million)
December of 2015.
decrease of 1.1%
versus 2014, when the company's sales were ¥1.96 billion.